Heather Sedgwick
Family · Suttons Bay, MINPI 1598251589
Payments from drug & device makers
Across 236 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$856
- GSK$714
- AstraZeneca$478
- Boehringer Ingelheim$328
- Amgen$283
- Novo Nordisk$267
- plus $2K from 23 others
What the payments were for
- Consulting fees$1754%
- Food & beverage$4,45794%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $856 |
| GSK | 39 | $714 |
| AstraZeneca | 29 | $478 |
| Boehringer Ingelheim | 16 | $328 |
| Amgen | 8 | $283 |
| Novo Nordisk | 18 | $267 |
| Lilly USA, LLC | 16 | $264 |
| Astellas Pharma US Inc | 8 | $211 |
| Dexcom, Inc. | 7 | $151 |
| Sanofi-aventis U.S. LLC | 1 | $147 |
| Otsuka America Pharmaceutical, Inc. | 6 | $143 |
| Bard Peripheral Vascular, Inc. | 1 | $141 |
| Pfizer | 7 | $125 |
| Exact Sciences | 6 | $124 |
| Bayer | 4 | $87 |
| Axsome Therapeutics, Inc. | 4 | $73 |
| Hologic Sales And Service, LLC | 1 | $61 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $48 |
| Indivior Inc. | 1 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 1 | $25 |
| Johnson & Johnson | 2 | $24 |
| Mylan Specialty L.p. | 2 | $22 |
| Corcept Therapeutics | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Novartis | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Antares Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$175
- TZIELD$147
- VENOVO$141
- TRELEGY ELLIPTA$125
How this compares
$4,732 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 11 | $142,603 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 48 | $40,275 |
| TrulicityDulaglutide | 37 | $36,012 |
| JardianceEmpagliflozin | 30 | $22,042 |
| MyrbetriqMirabegron | 28 | $19,068 |
| FarxigaDapagliflozin Propanediol | 24 | $17,963 |
| XareltoRivaroxaban | 13 | $6,962 |
| Atrovent HfaIpratropium Bromide | 12 | $5,302 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,349 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,158 |
| Atorvastatin Calcium | 121 | $1,836 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 17 | $1,813 |
| Rosuvastatin Calcium | 51 | $1,531 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $1,353 |
| Levothyroxine Sodium | 97 | $1,282 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $714 | $40,27548 claims |
| Lilly USA, LLCTrulicity | $264 | $36,01237 claims |
| Boehringer IngelheimJardiance | $328 | $22,04230 claims |
| AstraZenecaFarxiga, Symbicort | $478 | $20,31335 claims |
| Astellas Pharma US IncMyrbetriq | $211 | $19,06828 claims |
| Johnson & JohnsonXarelto | $24 | $6,96213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.
Other family in Suttons Bay
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.